CYP 2.33% 21.0¢ cynata therapeutics limited

FOMO is coming .., page-210

  1. 518 Posts.
    lightbulb Created with Sketch. 270
    smarty, Fuji haven’t said anything re CLI. However, Cynata has not recently been discussing an industry partner re CLI or even , at least recently, commenting that they are iseeking partners, simply stating they are progressing CLI themselves. Smarty, is the fact that they are not aggressively pursuing CLI industry partners suggesting to you that they are in talks with Fuji? And if so would you expect an announcement re gvhd and CLI at the same time? 

    Re takeover, Fuji mgmt can takeover now and make billions per year but you are exposing yourself to risks in phase 2...sure we’re confident given outstanding phase 1 and given phase 2 will replicate phase 1, but there is no certainty and as an executive at Fuji your reward on such risk would be minimal. Or you can wait until phase 2 further de risks and pay double then and still make billions per year. If I was an executive at Fuji I know which I’d pick. 

 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.